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Abstract
© 2016,  Springer  Science+Business  Media  New  York.The  discovery  and  development  of
effective  antihypoxic  drugs  is  an  important  issue  in  modern  experimental  and  clinical
pharmacology.  Complexes  of  zinc  containing  imidazole  cycles  as  ligands  are  promising
candidates for the design of novel drugs, including pharmacotherapeutic tools for patient’s
protection under conditions of oxygen deficiency. Herein, we report antihypoxic activity of zinc
complexes with N-alkenylimidazoles, and, specifically, a novel drug Acyzol, which can be used
as efficient antidote after poisoning by carbon monoxide and other combustion products.
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